Triglyceride glucose index in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study

  • 0Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.

|

|

Summary

This summary is machine-generated.

The Triglyceride-glucose (TyG) index is linked to increased risks of major adverse cardiovascular events and death in patients after percutaneous coronary intervention (PCI). This index may serve as an early predictor for cardiovascular risk management.

Area Of Science

  • Cardiology
  • Metabolic Syndrome Research
  • Clinical Risk Prediction

Background

  • The Triglyceride-glucose (TyG) index is increasingly recognized for its association with coronary artery disease development and severity.
  • Its predictive value for adverse cardiovascular outcomes post-percutaneous coronary intervention (PCI) remains largely uninvestigated.

Purpose Of The Study

  • To evaluate the association between the TyG index and major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS) undergoing PCI.
  • To determine if the TyG index can serve as an early predictor of cardiovascular risk in this patient population.

Main Methods

  • A cohort of 8019 ACS patients who underwent PCI was analyzed from the COSTIC research.
  • Baseline clinical data and TyG index were collected; MACE (cardiovascular death, all-cause death, myocardial infarction, stroke) were the primary endpoints.
  • Multivariate Cox proportional hazards models and restricted cubic splines were used to assess the TyG index-outcome relationship.

Main Results

  • An elevated TyG index was significantly associated with increased risk of MACE, cardiovascular death, and all-cause death per interquartile range increment.
  • Stratified analyses revealed significant interactions between the TyG index and sex, smoking status, and ACS diagnosis.
  • No non-linear relationship was detected between the TyG index and cardiovascular outcomes via restricted cubic splines.

Conclusions

  • The TyG index is a significant predictor of adverse cardiovascular outcomes, including mortality, in ACS patients post-PCI.
  • The TyG index shows potential as an early risk stratification tool or a therapeutic target in managing cardiovascular disease.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies 01:30

215

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT 01:25

395

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Coronary Artery Disease I: Introduction 01:30

882

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Angina IV: Management 01:26

237

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

Acute Coronary Syndrome IV:  Interprofessional Care 01:28

220

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Acute Coronary Syndrome I: Introduction 01:30

812

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...